產品詳情
簡單介紹：
Anti-phospho-NCF1 (Ser304)抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-phospho-NCF1 (Ser304)抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-phospho-NCF1 (Ser304)
Cat. Number:
Anti-phospho-NCF1 (Ser304)抗體KL-19047R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The protein encoded by this gene is a 47 kDa cytosolic subunit of neutrophil NADPH oxidase. This oxidase is a multicomponent enzymeAnti-phospho-NCF1 (Ser304)抗體 that is activated to produce superoxide anion. Mutations in this gene have been associated with chronic granulomatous disease. [provided by RefSeq, Jul 2008]
Also known as:
NCF1 (phospho S304); p-NCF1 (phospho S304); 47 kDa autosomal chronic granulomatous disease protein; 47 kDa neutrophil oxidase factor; Anti-phospho-NCF1 (Ser304)抗體NADPH oxidase organizer 2; NCF 47K; NCF-1; NCF-47K; Ncf1; NCF1_HUMAN; Neutrophil cytosol factor 1; Neutrophil cytosolic factor 1; neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1); Neutrophil NADPH oxidase factor 1; Nox organizer 2; Nox organizing protein 2; Nox-organizing protein 2; NOXO2; p47 phox; p47-phox; SH3 and PX domain containing protein 1A; SH3 and PX domain-containing protein 1A; SH3PXD1A.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Dog, Cow, Rabbit, Anti-phospho-NCF1 (Ser304)抗體Sheep, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human NCF1 around the phosphorylation site of Ser304.
●
Predicted Molecular Weight: 45kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-phospho-NCF1 (Ser304)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-phospho-NCF1 (Ser304)抗體
Optimal working dilutions must be determined by the end user.
